Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Should we be using kidneys from hepatitis C virus-infected donors?

Current opinion in nephrology and hypertension - 1 Nov 2011

Domínguez-Gil Beatriz, Andrés Amado, Campistol Jose M, Morales Jose M

Abstract excerpt

PURPOSE OF REVIEW: Transplantation of kidneys from donors with a positive serology for hepatitis C virus (HCVD positive) remains controversial. RECENT FINDINGS: Registry studies reported that the use of HCVD positive kidneys into HCV positive recipients is associated with shorter time awaiting transplantation but with a small increase in hazard for death and graft loss compared with HCVD negative. Notably,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepacivirus
Share to Hepatitis C
Share to Hepatitis C Antibodies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kidney Failure, Chronic

Share to Kidney Transplantation

Share to Risk Factors

Share to RNA, Viral

Share to Tissue Donors

Source

Identifiers

PMID: 21946162
DOI: 10.1097/MNH.0b013e32834bba37

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Should we be using kidneys from hepatitis C virus-infected donors?PMID 21946162Read ↗

Renal transplantation from donors with a positive serology for hepatitis C.Semantic proximity Read ↗

Transplantation of kidneys from Anti-HCV positive donors.Semantic proximity Read ↗

What are the management issues for hepatitis C in dialysis patients?: renal transplantation from hepatitis C-positive donors.Semantic proximity Read ↗

Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus-Infected Donors to Noninfected Recipients: An Open-Label Nonrandomized Trial.Semantic proximity Read ↗

Hepatitis C virus genotyping of organ donor samples to aid in transplantation of HCV-positive organs.Semantic proximity Read ↗

Use of direct-acting agents for hepatitis C virus-positive kidney transplant candidates and kidney transplant recipients.Semantic proximity Read ↗

The Moral Necessity to Increase Access to HCV+ Transplants With Early Treatment for HCV-naive Patients.Semantic proximity Read ↗

Impact of hepatitis C virus infection on short-term outcome in renal transplantation: a single-center study.Semantic proximity Read ↗

The burden of anti-HCV genotye-4 positivity in renal transplant recipients: 8 years follow-up.Semantic proximity Read ↗

Twelve-Month Outcomes After Transplant of Hepatitis C-Infected Kidneys Into Uninfected Recipients: A Single-Group Trial.Semantic proximity Read ↗

Hepatitis C virus genotype does not affect patient survival among renal transplant candidates. The New England Organ Bank Hepatitis C Study Group.Semantic proximity Read ↗

Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.